Geode Capital Management, LLC Vaxxinity, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.62 - $0.86 $22,647 - $31,414	36,529 Added 4.34%	878,543 $632,000
Q4 2023 Feb 13, 2024	BUY	$0.7 - $1.31 $8,548 - $15,997	12,212 Added 1.47%	842,014 $715,000
Q3 2023 Nov 13, 2023	BUY	$1.25 - $3.0 $56,357 - $135,258	45,086 Added 5.75%	829,802 $1.14 Million
Q2 2023 Aug 11, 2023	BUY	$1.73 - $2.79 $702,251 - $1.13 Million	405,926 Added 107.16%	784,716 $1.98 Million
Q1 2023 May 15, 2023	BUY	$1.43 - $4.24 $40,659 - $120,555	28,433 Added 8.12%	378,790 $859,000
Q4 2022 Feb 13, 2023	BUY	$1.31 - $2.62 $17,720 - $35,440	13,527 Added 4.02%	350,357 $490,000
Q3 2022 Nov 14, 2022	BUY	$1.64 - $2.48 $440,723 - $666,460	268,734 Added 394.64%	336,830 $666,000
Q4 2021 Feb 11, 2022	BUY	$5.55 - $18.46 $377,932 - $1.26 Million	68,096 New	68,096 $382,000

198K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.